Myriad Genetics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 195.9 million compared to USD 202.2 million a year ago. Net loss was USD 0.1 million compared to USD 26 million a year ago.
Myriad Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
Published on 05/06/2025 at 16:09
Share
Share
© S&P Capital IQ - 2025